Evaluation of the efficacy of MONTANIDE™ GR01, a new adjuvant for feed-based vaccines, on the immune response and protection against Streptococcus agalactiae in oral vaccinated Nile tilapia (Oreochromis niloticus) under laboratory and on-farm conditions
-
Published:2024-06
Issue:
Volume:149
Page:109567
-
ISSN:1050-4648
-
Container-title:Fish & Shellfish Immunology
-
language:en
-
Short-container-title:Fish & Shellfish Immunology
Author:
Pholchamat Sirinya,
Vialle Regis,
Luang-In VijitraORCID,
Phadee Panarat,
Wang Bei,
Wang TiehuiORCID,
Secombes Christopher J.,
Wangkahart EakapolORCID
Reference58 articles.
1. Strategies to enhance tilapia immunity to improve their health in aquaculture;Wang;Rev. Aquacult.,2023
2. First comprehensive proteome analysis of lysine crotonylation in Streptococcus agalactiae, a pathogen causing meningoencephalitis in teleosts;Chen;Proteome Sci.,2021
3. Optimum dietary sources and levels of selenium improve growth, antioxidant status, and disease resistance: re-evaluation in a farmed fish species, Nile tilapia (Oreochromis niloticus);Wangkahart;Fish Shellfish Immunol.,2022
4. Systemic and mucosal antibody response of freshwater cultured Asian seabass (Lates calcarifer) to monovalent and bivalent vaccines against Streptococcus agalactiae and Streptococcus iniae;Lan;Fish Shellfish Immunol.,2021
5. Disease outbreaks in farmed Amazon catfish (Leiarius marmoratus x Pseudoplatystoma corruscans) caused by Streptococcus agalactiae, S. iniae, and S. dysgalactiae;Tavares;Aquaculture,2018